These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37723198)
1. A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors. Marques Da Costa ME; Zaidi S; Scoazec JY; Droit R; Lim WC; Marchais A; Salmon J; Cherkaoui S; Morscher RJ; Laurent A; Malinge S; Mercher T; Tabone-Eglinger S; Goddard I; Pflumio F; Calvo J; Redini F; Entz-Werlé N; Soriano A; Villanueva A; Cairo S; Chastagner P; Moro M; Owens C; Casanova M; Hladun-Alvaro R; Berlanga P; Daudigeos-Dubus E; Dessen P; Zitvogel L; Lacroix L; Pierron G; Delattre O; Schleiermacher G; Surdez D; Geoerger B Commun Biol; 2023 Sep; 6(1):949. PubMed ID: 37723198 [TBL] [Abstract][Full Text] [Related]
2. The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models. Tanaka K; Kato I; Dobashi Y; Imai JI; Mikami T; Kubota H; Ueno H; Ito M; Ogawa S; Nakahata T; Takita J; Toyoda H; Ogawa C; Adachi S; Watanabe S; Goto H Cancer Sci; 2022 Nov; 113(11):3814-3825. PubMed ID: 35879192 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies. Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699 [TBL] [Abstract][Full Text] [Related]
4. Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS. Chaix J; Schleiermacher G; Corradini N; André N; Thebaud E; Gambart M; Defachelles AS; Entz-Werle N; Chastagner P; De Carli É; Ducassou S; Landman-Parker J; Adam-de-Beaumais T; Larive A; Michiels S; Vassal G; Valteau-Couanet D; Geoerger B; Berlanga P Eur J Cancer; 2024 Apr; 201():113923. PubMed ID: 38377775 [TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization. Sun S; Zhang Z Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009 [TBL] [Abstract][Full Text] [Related]
7. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models. Okada S; Vaeteewoottacharn K; Kariya R Cells; 2019 Aug; 8(8):. PubMed ID: 31412684 [TBL] [Abstract][Full Text] [Related]
8. Creation and Maintenance of a Living Biobank - How We Do It. Bürtin F; Matschos S; Prall F; Mullins CS; Krohn M; Linnebacher M J Vis Exp; 2021 Apr; (170):. PubMed ID: 33900297 [TBL] [Abstract][Full Text] [Related]
9. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine. Okada S; Vaeteewoottacharn K; Kariya R Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256 [TBL] [Abstract][Full Text] [Related]
11. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. Berlanga P; Pierron G; Lacroix L; Chicard M; Adam de Beaumais T; Marchais A; Harttrampf AC; Iddir Y; Larive A; Soriano Fernandez A; Hezam I; Chevassus C; Bernard V; Cotteret S; Scoazec JY; Gauthier A; Abbou S; Corradini N; André N; Aerts I; Thebaud E; Casanova M; Owens C; Hladun-Alvaro R; Michiels S; Delattre O; Vassal G; Schleiermacher G; Geoerger B Cancer Discov; 2022 May; 12(5):1266-1281. PubMed ID: 35292802 [TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenograft models: an emerging platform for translational cancer research. Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190 [TBL] [Abstract][Full Text] [Related]
13. [Knowledge and practice of patient-derived xenograft models in leukemia]. Kato I Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560 [TBL] [Abstract][Full Text] [Related]
14. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer. Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209 [TBL] [Abstract][Full Text] [Related]
15. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models. Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676 [TBL] [Abstract][Full Text] [Related]
16. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments. Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156 [TBL] [Abstract][Full Text] [Related]
17. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models]. Pauli C; Moch H; Rubin MA Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107 [TBL] [Abstract][Full Text] [Related]
18. The future of patient-derived tumor xenografts in cancer treatment. Sia D; Moeini A; Labgaa I; Villanueva A Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657 [TBL] [Abstract][Full Text] [Related]
19. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer. Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086 [TBL] [Abstract][Full Text] [Related]
20. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments. Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]